Topic: drug prices

Chutes & Ladders: Three key Valeant execs jump ship

A trio of top execs exit embattled Valeant, Genentech promotes Bill Anderson to CEO, and Alexion replaces its CEO and CFO amid an internal Soliris sales probe. Plus more hirings, firings and retirings throughout the industry.